Overview

Efficacy and Safety of Dingkundan Combined With Compound Oral Contraceptives in the Treatment of PCOS: an Open-label, Randomized Controlled Study

Status:
Recruiting

Trial end date:
2024-03-01

Target enrollment:

Participant gender:

Summary

This is a single-center, randomized, open-label clinical study to investigate the efficacy and safety of Dingkundan (DKP) combined with compound oral contraceptives (COC) in the treatment of PCOS. This study is mainly to compare the effect of COC plus DKP verse COC on reducing androgen, improving the function of ovarian and the individual metabolism. The secondary objective of our study is to explore the efficacy of DKP on pregnancy in patients with PCOS and its safety.

Phase:

N/A

Details

Lead Sponsor:

Guangdong Women and Children Hospital

Treatments:

Drospirenone
Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol